SPRINGFIELD PHARMACY (RICHMOND) LIMITED

Registered number

06305132

Unaudited Filleted Accounts

31 July 2025

SPRINGFIELD PHARMACY (RICHMOND) LIMITED
Registered number:		06305132
Balance Sheet
as at 31 July 2025

Notes			2025			2024
£				£
Fixed assets
Intangible assets	3		41,929			65,887
Tangible assets	4		308,433			320,452
			350,362			386,339

Current assets
Stocks		61,081			100,028
Debtors	5	1,227,321			1,111,387
Cash at bank and in hand		42,490			25,516
		1,330,892			1,236,931

Creditors: amounts falling due within one year	6	(282,388)			(363,017)

Net current assets			1,048,504			873,914

Total assets less current liabilities			1,398,866			1,260,253

Creditors: amounts falling due after more than one year	7		(38,155)			(139,266)



Net assets			1,360,711			1,120,987

Capital and reserves
Called up share capital			100			100
Share premium			70,000			70,000
Profit and loss account			1,290,611			1,050,887

Shareholder's funds			1,360,711			1,120,987

The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.




Sam Hedayati
Director
Approved by the board on 11 May 2026

SPRINGFIELD PHARMACY (RICHMOND) LIMITED
Notes to the Accounts
for the year ended 31 July 2025


1	Accounting policies

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Turnover
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Tangible fixed assets
	Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:

	Freehold buildings			Nil
	Buildings			10% on cost
	Plant and machinery			25% on cost
	Fixtures and fittings			25% on cost
	Office equipment			33% on cost

	Goodwill
	Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities, and contingent liabilities of the entity recognized at the date of acquisition. Goodwill is initially recognized as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. It is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

	Amortisation
	Amortisation is provided on intangible assets to write off the cost, less any estimated residual value, over their useful life as follows:
	Asset Class			Amortisation method and rate
	Goodwill			5% on cost

	Cash and cash equivalents
	Cash and cash equivalents consist of cash on hand, call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.



	Stocks
	Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method. The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labor costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

	Debtors
	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

	Creditors
	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

	Taxation
	A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

	Borrowings
	Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing. Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges. Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.





	Leases
	Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.



2	Employees					2025		2024
Number							Number

	Average number of persons employed by the company					4		4


3	Intangible fixed assets							£
	Goodwill:

	Cost
	At 1 August 2024							479,165
	At 31 July 2025							479,165

	Amortisation
	At 1 August 2024							413,278
	Provided during the year							23,958
	At 31 July 2025							437,236

	Net book value
	At 31 July 2025							41,929
	At 31 July 2024							65,887

	Goodwill is being written off in equal annual instalments over its estimated economic life of 5 years.


4	Tangible fixed assets
		Land and buildings		Plant and machinery etc		Fixtures and Fittings		Total
£			£		£		£
	Cost
	At 1 August 2024	380,000		20,000		79,779		479,779
	At 31 July 2025	380,000		20,000		79,779		479,779

	Depreciation
	At 1 August 2024	64,000		20,000		75,327		159,327
	Charge for the year	8,000		-		4,019		12,019
	At 31 July 2025	72,000		20,000		79,346		171,346

	Net book value
	At 31 July 2025	308,000		-		433		308,433
	At 31 July 2024	316,000		-		4,452		320,452


5	Debtors					2025		2024
£							£

	Trade debtors					61,083		77,211
	Amounts owed by group undertakings and undertakings in which the company has a participating interest					1,166,238		1,034,176
						1,227,321		1,111,387


6	Creditors: amounts falling due within one year					2025		2024
£							£

	Bank loans and overdrafts					66,701		44,415
	Trade creditors					131,046		198,333
	Accruals					2,750		40,750
	Taxation and social security costs					49,458		23,020
	Other creditors					32,433		56,499
						282,388		363,017


7	Creditors: amounts falling due after one year					2025		2024
£							£

	Bank loans					38,155		139,266


8	Other information

	SPRINGFIELD PHARMACY (RICHMOND) LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
	277-279 Chiswick High Road
	London
	W4 4PU